Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Drug Induced Liver Disease
How do you counsel patients on the use and risks of alternative medications and supplements given how prevalent and easily accessible they are to the average person and their risk of liver injury?
Related Questions
When do you pursue liver biopsy for assessment of DILI?
How would you approach the management of drug-induced autoimmune hepatitis compared to non-drug-induced autoimmune hepatitis?
How do you approach fertility/family planning and counseling in patients with end-stage liver disease?
Is the Enhanced Liver Fibrosis (ELF) test superior to the FIB-4 test in the diagnosis of MASLD?
When treating fatty liver disease with resmetirom, how often should a FibroScan be repeated to assess treatment response?
What pre-transplant patient factors impact surveillance intervals and methods after liver transplant for HCC?
What is your approach to the management of post-TIPS hepatic encephalopathy?
What are your biggest takeaways from the MASH-TAG 2025 conference?
How do you explain the additional risks that a transplant recipient may carry by pursuing a hepatitis C positive organ if they are negative?
What variables do you weigh most heavily when choosing which copper chelation therapy you'll recommend for a patient?